U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Mendy M, Caboux E, Lawlor RT, et al. Common Minimum Technical Standards and Protocols for Biobanks Dedicated to Cancer Research. Lyon (FR): International Agency for Research on Cancer; 2017. (IARC Technical Report, No. 44.)

Cover of Common Minimum Technical Standards and Protocols for Biobanks Dedicated to Cancer Research

Common Minimum Technical Standards and Protocols for Biobanks Dedicated to Cancer Research.

Show details

ANNEX 4. Template Material/Data Transfer Agreement (MTA/DTA)

This template is based on the IARC MTA template. The text presents generic template language (italic means that text must be adapted).

[Insert logo of Providing Institute]

MATERIAL AND DATA TRANSFER AGREEMENT – MTA/DTA

MTA/DTA Reference Number: [to be provided by [insert name of Providing Institute]]

Subject to the terms and conditions of this Agreement, the [insert name of Providing Institute] hereby agrees to provide, and the Receiving Institute hereby agrees to accept, the Materials and Information specified below for such Purposes of Use and subject to such Restrictions on Use as specified below.

In this Agreement, the following expressions shall have the following meanings:

1. “Providing Institute”:

[Insert name and full address of Providing Institute]

Contact: [insert name and contact details (including email address) of Providing Institute’s Principal Investigator]

2. “Receiving Institute”:

[Insert name and full address of Receiving Institute]

Contact: [insert name and contact details (including email address) of Receiving Institute’s Principal Investigator]

3. “Materials”:

[Insert precise description of Materials], held by [insert name of Providing Institute], and made available to the Receiving Institute hereunder in a quantity of [insert quantity to be provided by Providing Institute].

4. “Information”:

Any information, unpublished or otherwise, owned by [insert name of Providing Institute] and communicated to the Receiving Institute by [insert name of Providing Institute] during the term of this Agreement relating to the Materials, their production, properties, and/or experimental results observed using the Materials or any derivatives therefrom.

5. “Purposes of Use”:

The Materials and Information are provided for the following purposes, as more fully described in Appendix 2 (the “Research Project”):

[Insert a brief description of the purposes for which the Materials, and products incorporating or developed with the Materials, may be used.] [Add reference to a specific grant, etc. when appropriate.]

6. “Restrictions on Use”:

The Materials and Information shall not be used for any purpose other than the Purposes of Use.

In particular, the Materials and Information shall not be used for [insert any specific restrictions on use].

7. “Term of Agreement”:

This Agreement shall remain in full force and effect as from the date of its signature by both parties for a duration of [specify duration/may be based on project duration].

8. “Materials Charges”:

Please keep THE applicable clause (1) and delete the rest.

8.1 As per price list The cost of sample retrieval, processing –including DNA extraction– packaging, and shipment will be charged by [insert name of Providing Institute] to the Receiving Institute at the latest rate [indicate where rate will be made available for informational purposes].

or

8.1 As per agreed unit price The cost of sample retrieval, processing –including DNA extraction– packaging, and shipment will be charged by [insert name of Providing Institute] to the Receiving Institute at the following agreed rate: [list unit price].

or

8.1 Lump sum amount The cost of sample retrieval, processing –including DNA extraction– packaging, and shipment will be charged by [insert name of Providing Institute] to the Receiving Institute for the total lump sum amount of [amount and currency in words].

or

8.1 Free of charge The sample retrieval, processing –including DNA extraction– packaging, and shipment will be provided free of charge.

9. “General Conditions”:

The General Conditions attached hereto under Appendix 1 form an integral part of this Agreement.

This Agreement is duly signed on behalf of the parties as follows:

Signed for and on behalf of [Providing Institute]: Signed for and on behalf of Receiving Institute:

_________________________________ _________________________________

[Providing Institute] Responsible Scientist Receiving Institute Responsible Scientist

Name: ___________________________ Name: ___________________________

Title: ____________________________ Title: ____________________________

_________________________________ _________________________________

[Providing Institute] Authorized Official Receiving Institute Authorized Official

Name: ___________________________ Name: ___________________________

Title: ____________________________ Title: ____________________________

Date: ____________________________ Date: ____________________________

APPENDIX 1 – GENERAL CONDITIONS

1. Use

1.1 The Materials and Information are supplied by [insert name of Providing Institute] to the Receiving Institute solely for the Purposes of Use and subject to the Restrictions on Use as set out herein.

1.2 The Materials and Information shall not be used in human subjects, in clinical trials, or for diagnostic purposes involving human subjects without the written consent of [insert name of Providing Institute].

1.3 Other than for and within the Purposes of Use, and as specifically described in Appendix 2, the Materials and Information shall not be transferred, offered for sale, or otherwise used without the prior written agreement of [insert name of Providing Institute].

1.4 The Receiving Institute shall allow only parties who have a need to know for the Purposes of Use and who are bound by similar obligations of confidentiality and Restrictions on Use as contained in this Agreement to have access to the Materials and Information.

1.5 The Receiving Institute shall require any party handling and/or using the Materials and Information to comply with all relevant laws, rules, and regulations applicable to the use of such Materials and Information.

2. Confidentiality

2.1 The Information may incorporate confidential information of [insert name of Providing Institute]. Accordingly, if and to the extent that any such Information is clearly marked as “confidential”, the Receiving Institute shall during the Term of this Agreement and for a period of [insert number of years] years following its termination treat such Information as confidential and only disclose it under like obligations of confidentiality and Restrictions on Use as those contained herein. The Receiving Institute shall be deemed to have fulfilled its obligations if it exercises at least the same degree of care in maintaining confidentiality as it would in protecting its own confidential information.

2.2 The above-mentioned obligations of confidentiality shall not apply to Information which:

(i) can be shown to have been known to the Receiving Institute at the time of its acquisition from [insert name of Providing Institute]; or

(ii) is acquired from a third party, not in breach of any confidentiality obligation to [insert name of Providing Institute]; or

(iii) is independently devised or arrived at by, on behalf of, or for the Receiving Institute without access to the Information; or

(iv) enters the public domain otherwise than by breach of the undertakings set out in this Agreement.

2.3 In some cases, the Information may also incorporate confidential information pertaining to research participants having provided the Materials. The Materials provided to the Receiving Institute have been [coded or anonymized (provide description of data treatment here)]. If the Receiving Institute inadvertently receives information that identifies individual research participants, the Receiving Institute will take all reasonable and appropriate steps to protect the privacy and confidentiality of such information. This may require immediate destruction of the information on request of [insert name of Providing Institute]. The Receiving Institute agrees to make no intentional attempt to re-identify research participants through linkage of data or otherwise. The Receiving Institute will immediately report any identification of research participants to [insert name of Providing Institute].

3. Rights

3.1 Except for the rights explicitly granted hereunder, nothing contained in this Agreement shall be construed as conveying any rights under any patents or other intellectual property which either party may have or may hereafter obtain.

3.2 [Insert name of Providing Institute] shall retain ownership of the Materials and Information and shall have the unrestricted right to use, assign, or distribute the Materials and Information to any third parties for any other purposes. The Receiving Institute acknowledges and agrees that nothing contained in this Agreement shall be deemed to grant to the Receiving Institute any intellectual property rights in any of the Materials or Information provided hereunder.

3.3 The Receiving Institute must not make intellectual property claims on Materials or Information derived directly from [insert name of Providing Institute]. However, the importance of downstream inventions made with [insert name of Providing Institute] Materials is recognized; patents on such inventions are permitted. In doing so, the Receiving Institute agrees to implement licensing policies that will not obstruct further research. The Receiving Institute will own all results, data, and inventions which arise under the Research Project described in Appendix 2.

OPTIONAL ADDITIONAL CLAUSE: The Receiving Institute do, however, grant to [insert name of Providing Institute] a perpetual, non-cancellable, royalty-free, worldwide license, with right to sublicense, to use study results for all purposes.

4. Return of Individual-Level Results

OPTIONAL CLAUSES:

4.1 No return of individual-level results: Individual Research Results and Incidental Findings will not be returned to [insert name of Providing Institute].

or

4.1 Return of individual-level results: Participants in [insert name of Providing Institute] have consented to the return of Individual Research Results and Incidental Findings that are clinically significant, analytically valid, and actionable (i.e. treatable or preventable). If in the course of their research the Receiving Institute comes across such findings, they must be returned to the [insert name of Providing Institute].

5. Publications

5.1 Upon completion of the Research Project, the Receiving Institute will send to [insert name of Providing Institute] [specify: reports, enriched data, etc.]. The Receiving Institute must endeavour to publish results in an academic journal or in an open access database. The Receiving Institute agrees to acknowledge [insert name of Providing Institute] in any publication or presentation on work derived in whole or in part from the Materials and to supply [insert name of Providing Institute] with a copy or web address of any publication.

6. Warranties and Liabilities

6.1 [Insert name of Providing Institute] makes no warranty of the fitness of the Materials for any particular purpose or any other warranty, either express or implied. However, to the best of [insert name of Providing Institute]’s knowledge, the use of the Materials and/or Information within the Purposes of Use shall not infringe on the proprietary rights of any third party.

6.2 [Insert name of Providing Institute] will not be liable for damages related to the provision of Materials to the Receiving Institute. This includes but is not limited to damages in relation to inaccuracies, lack of comprehensiveness, or use of the Information and Materials and/or Information, or any delay or break in supply by [insert name of Providing Institute]. The Receiving Institute acknowledges that [insert name of Providing Institute] makes no guarantee that the Materials and/or Information are free of contamination from viruses, latent viral genomes, or other infectious agents. The Receiving Institute agrees to treat the Materials as if they were not free from contamination, to ensure that appropriate biosafety training is provided to research personnel, and to implement appropriate biohazard containment measures.

6.3 The Receiving Institute agrees that, except as may explicitly be provided in this Agreement, [insert name of Providing Institute] has no control over the use that is made of the Materials or the Information by the Receiving Institute in accordance with the terms of this Agreement. Consequently, the Receiving Institute agrees that [insert name of Providing Institute] shall not be liable for such use.

7. Amendment, Extension, and Termination

7.1 Any amendment to this Agreement, including extension of the Term of Agreement, shall be valid only by written amendment executed by the duly authorized officers of both parties.

7.2 Notwithstanding the conditions set forth in this Agreement, in particular the Purposes of Use, Restrictions on Use, and Confidentiality obligations, either party may terminate this Agreement with sixty (60) days prior written notice to the other party.

7.3 When the Research Project is completed or this Agreement is terminated, whichever comes first, any unused Materials will either be destroyed in compliance with all applicable statutes and regulations or will be returned to [insert name of Providing Institute] by the Receiving Institute upon [insert name of Providing Institute]’s request.

8. Miscellaneous

8.1 Nothing in this Agreement shall be interpreted as establishing a partnership between the parties or establishing one party as the agent of the other or conferring a right on one party to bind the other, except as may be specifically set out herein.

8.2 Any dispute relating to the interpretation or application of this Agreement shall, unless amicably settled, be subject to conciliation. In the event of failure of the latter, the dispute shall be settled by arbitration. The arbitration shall be conducted in accordance with the modalities to be agreed upon by the parties or, in the absence of agreement, with the rules of arbitration of the International Chamber of Commerce. The parties shall accept the arbitral award as final.

8.3 This Agreement sets forth the entire understanding between the parties and supersedes any prior agreements, written or verbal.

APPENDIX 2 – RESEARCH PROJECT

[Provide description of project/work to be performed using the Materials and/or Information.]

© International Agency for Research on Cancer, 2017. For more information contact publications@iarc.fr.
Bookshelf ID: NBK567253

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (2.5M)

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...